Morning Market Movers
December 09, 2014 at 09:40 AM EST
bluebird bio (NASDAQ: BLUE) shares climbed 57.50% to $77.00 following an announcement of positive data for its LentiGlobin BB305 drug. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.